MedPath

Comparison of the effect of ketamine and magnesium sulfate on pain control after spinal surgery.

Phase 3
Recruiting
Conditions
Condition 1: Candidate for laminectomy and discectomy and screw and plaque implantation by posterior lumbar and sacral spine CD. Condition 2: Spondylopathies.
Postlaminectomy syndrome, not elsewhere classified
M96.1
M45-M49
Spondylopathies
Registration Number
IRCT20170413033408N6
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

Class 1 or 2 ASA based on the physical condition of the American Anesthesia Association.
Subjects in the age range of 18-65 years.
Candidate for laminectomy and discectomy and screw and plaque implantation by posterior lumbar and sacral spine CD.

Exclusion Criteria

Previous history of lumbosacral surgery.
History of schizophrenia and use of antipsychotic drugs.
History of calcium channel blockers.
History of neuropathy and myopathy.
History of kidney damage requires dialysis in the past.
Presence of conduction system abnormalities in the ECG taken from the patient.
History of ketamine allergy.
The length of stay after surgery is less than 48 hours.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative pain score. Timepoint: Pain score since entering recovery,6, 12, 24, 36 and 48 hours after surgery will be measured. Method of measurement: Based on VAS measurement criteria.;Postoperative sedation rate. Timepoint: Sedation score since entering recovery,6, 12, 24, 36 and 48 hours after surgery will be measured. Method of measurement: Based on RSS measurement criteria.;Hemodynamic changes. Timepoint: The patient's hemodynamic monitoring will be performed from the time of entering the operating room until the end of the operation. Method of measurement: Hemodynamic criteria (heart rate, systolic, diastolic, and mean arterial blood pressure (MABP), arterial oxygen saturation) of the patient will be measured by Saadat monitoring.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath